EVs secreted by cancer cells contain pro-angiogenic mediators, including vascular endothelial growth factor (VEGFA), interleukin-8 (IL-8), interleukin 6 (IL-6) and fibroblast growth factor 2 (FGF2). This evidence concerns the gene VEGFA and cancer.